[HTML][HTML] Metformin: Is it a drug for all reasons and diseases?

CR Triggle, I Mohammed, K Bshesh, I Marei, K Ye… - Metabolism, 2022 - Elsevier
Metformin was first used to treat type 2 diabetes in the late 1950s and in 2022 remains the
first-choice drug used daily by approximately 150 million people. An accumulation of …

Drug safety of frequently used drugs and substances for self-medication in COVID-19

D Baracaldo-Santamaría… - … advances in drug …, 2022 - journals.sagepub.com
During the COVID-19 pandemic, the behavior of self-medication has increased. The
dissemination of misleading information regarding the efficacy of certain drugs or …

[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …

ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …

Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma

S Ramzy, AH Abdelazim, AOE Osman… - Spectrochimica Acta Part …, 2022 - Elsevier
Favipiravir, remdesivir and hydroxychloroquine have been suggested in COVID-19
Treatment Guidelines Panel of many countries. Synchronous spectrofluorometric …

[HTML][HTML] Chloroquine and hydroxychloroquine toxicity

TJ Stokkermans, DM Falkowitz, G Trichonas - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Objectives: Identify the treatment indications for chloroquine and hydroxychloroquine.
Determine the mechanisms of action of chloroquine and hydroxychloroquine. Identify the …

COVID-19 therapeutic potential of natural products

Z Low, R Lani, V Tiong, C Poh, S AbuBakar… - International Journal of …, 2023 - mdpi.com
Despite the fact that coronavirus disease 2019 (COVID-19) treatment and management are
now considerably regulated, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

[HTML][HTML] Hydroxychloroquine/chloroquine as therapeutics for COVID-19: truth under the mystery

Y Chen, MX Li, GD Lu, HM Shen… - International Journal of …, 2021 - ncbi.nlm.nih.gov
The outbreak of coronavirus disease-19 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. One …

[HTML][HTML] Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 …

FA Cadegiani, A Goren, CG Wambier… - New microbes and new …, 2021 - Elsevier
In a prospective observational study (pre-AndroCoV Trial), the use of nitazoxanide,
ivermectin and hydroxychloroquine demonstrated unexpected improvements in COVID-19 …

Systemic lupus erythematosus and COVID-19

M Pappa, A Panagiotopoulos, K Thomas… - Current Rheumatology …, 2023 - Springer
Abstract Purpose of Review To describe the current state of knowledge regarding COVID-19
in patients with systemic lupus erythematosus (SLE). We focus on (i) SARS-CoV-2 …

Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome

J Liu, L Zhang, Y Tian, S Wan, M Hu… - Journal of Cellular …, 2022 - Wiley Online Library
Obstetric antiphospholipid syndrome (OAPS) is mediated by antiphospholipid antibodies
(aPLs, and anti‐β2 glycoprotein I antibody is the main pathogenic antibody), and recurrent …